HDAC inhibitors have been studied with respect to their potential use as topical treatments, with a view to developing a means for rapid penetration into the skin for the treatment of melanoma and arthritis (for example, Chung et al., 2004, Gowda et al., 2012). This evidence concerns the gene HDAC9 and melanoma.